Press Release

Dorsey Launches ERISA Insights Blog

Issued by Dorsey & Whitney LLP

Mar. 2, 2022

MINNEAPOLIS -- International law firm Dorsey & Whitney LLP announced today that the Firm’s ERISA Litigation Practice Group has launched a new blog: ERISA Insights. The blog will keep readers up-to-date on the latest cases, regulations, and trends in ERISA litigation and compliance. Visit the blog at: https://www.dorseyerisa.com/.

Dorsey Partner Andrew Holly, serves as managing editor, and Associate Nick Bullard, as manager, the blog will cover all the cutting-edge ERISA stories, keeping a pulse on case law, regulatory, and legislative developments in the areas of employee benefits and ERISA.

Dorsey’s ERISA Litigation practice represents businesses, employers, plan administrators, payors and fiduciaries in lawsuits challenging the management and administration of health, retirement, and other benefit plans under ERISA and related laws. In order to achieve the best result for each client, we draw upon expertise of Dorsey’s litigators, employee benefits attorneys, and other specialists. Our knowledge and experience with compensation and benefits, insurance law, labor and employment, securities and financial services litigation and enforcement and tax controversy help us successfully resolve complex benefits disputes for our clients.

About Dorsey & Whitney LLP

Clients have relied on Dorsey since 1912 as a valued business partner. With locations across the United States and in Canada, Europe and the Asia-Pacific region, Dorsey provides an integrated, proactive approach to its clients' legal and business needs. Dorsey represents a number of the world's most successful companies from a wide range of industries, including leaders in banking & financial institutions, development & infrastructure, energy & natural resources, food, beverage & agribusiness, healthcare and technology, as well as major non-profit and government entities. 

Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink.